{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:03:50Z","timestamp":1790787830329,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.physbeh.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T06:17:56Z","timestamp":1402640276000},"page":"119-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":278,"special_numbering":"C","title":["\u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice"],"prefix":"10.1016","volume":"135","author":[{"given":"Amine","family":"Bahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamma","family":"Al Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyazia","family":"Al Memari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouza","family":"Al Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M","family":"Nurulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreesh","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2014.06.003_bb0005","first-page":"16","article-title":"Psychiatric disorders: a global look at facts and figures","volume":"7","author":"Sansone","year":"2010","journal-title":"Psychiatry (Edgmont (Pa. : Township))"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2009.369","article-title":"Impairments in endocannabinoid signaling and depressive illness","volume":"301","author":"Hill","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","article-title":"Endocannabinoid system dysfunction in mood and related disorders","volume":"124","author":"Ashton","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0074-7742(09)88012-4","article-title":"Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications","volume":"88","author":"Onaivi","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10253890.2011.586753","article-title":"Endocannabinoids and stress","volume":"14","author":"Riebe","year":"2011","journal-title":"Stress"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0026-895X(25)10254-X","article-title":"Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase","volume":"48","author":"Slipetz","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0074-7742(08)60667-4","article-title":"Molecular neurobiology of the cannabinoid receptor","volume":"39","author":"Abood","year":"1996","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2009_16","article-title":"Cannabinoids and anxiety","volume":"2","author":"Moreira","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(01)00130-9","article-title":"The endocannabinoid nervous system: unique opportunities for therapeutic intervention","volume":"90","author":"Porter","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0065","first-page":"672","article-title":"The endocannabinoid system: a drug discovery perspective","volume":"6","author":"Piomelli","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","article-title":"Cannabinoid receptors as therapeutic targets","volume":"46","author":"Mackie","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects","volume":"5","author":"Marco","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0165-6147(96)10015-8","article-title":"Benzodiazepines on trial: a research strategy for their rehabilitation","volume":"17","author":"Costa","year":"1996","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.physbeh.2014.06.003_bb0085","first-page":"S39","article-title":"Nonselective and selective benzodiazepine receptor agonists\u2014where are we today?","volume":"23","author":"Mitler","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0090","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1016\/j.bmcl.2010.08.126","article-title":"Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands","volume":"20","author":"Tong","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/13543770903436505","article-title":"Latest advances in cannabinoid receptor agonists","volume":"19","author":"Thakur","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1476-5381.2010.00745.x","article-title":"Phytocannabinoids beyond the Cannabis plant\u2014do they exist?","volume":"160","author":"Gertsch","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0105","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11655-013-1354-5","article-title":"Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L.","volume":"19","author":"Asgarpanah","year":"2013","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0115","first-page":"1775","article-title":"Essential oils from the Hyptis genus\u2014a review (1909\u20132009)","volume":"6","author":"McNeil","year":"2011","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0120","first-page":"60","article-title":"Aphids, predators and parasitoids","volume":"223","author":"Wadhams","year":"1999","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0125","doi-asserted-by":"crossref","first-page":"e0022","DOI":"10.5041\/RMMJ.10129","article-title":"The endocannabinoid system, cannabinoids, and pain","volume":"4","author":"Fine","year":"2013","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1447-0756.2011.01802.x","article-title":"Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial","volume":"38","author":"Ou","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0135","first-page":"1225","article-title":"[GC\u2013MS analysis and analgesic activity of essential oil from fresh rhizoma of Cyperus rotundus]","volume":"34","author":"Chen","year":"2011","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3109\/13880209.2010.491083","article-title":"Chemical composition and analgesic activity of Senecio rufinervis essential oil","volume":"48","author":"Mishra","year":"2010","journal-title":"Pharm Biol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0145","first-page":"76","article-title":"Antinociceptive effects of the essential oil of Dracocephalum kotschyi in the mouse writhing test","volume":"7","author":"Golshani","year":"2004","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pnpbp.2012.04.012","article-title":"The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, beta-caryophyllene, in male mice","volume":"38","author":"Galdino","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0155","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","article-title":"Beta-caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARgamma pathway","volume":"178","author":"Bento","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0160","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.freeradbiomed.2012.01.014","article-title":"Beta-caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner","volume":"52","author":"Horvath","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2013.01.023","article-title":"Individual differences in elevated plus-maze exploration predicted higher ethanol consumption and preference in outbred mice","volume":"105","author":"Bahi","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/10253890.2012.754419","article-title":"Increased anxiety, voluntary alcohol consumption and ethanol-induced place preference in mice following chronic psychosocial stress","volume":"16","author":"Bahi","year":"2013","journal-title":"Stress"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0175","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.euroneuro.2012.01.008","article-title":"Hippocampus-specific deletion of tissue plasminogen activator \u201ctPA\u201d in adult mice impairs depression- and anxiety-like behaviors","volume":"22","author":"Bahi","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0180","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.biopsych.2009.07.004","article-title":"Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice","volume":"66","author":"Bahi","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","article-title":"The psychiatric side-effects of rimonabant","volume":"31","author":"Moreira","year":"2009","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","article-title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","volume":"205","author":"Le Foll","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0215","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"25","author":"Garcia-Gutierrez","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0230","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neuropharm.2004.12.008","article-title":"Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy","volume":"48","author":"Valenzano","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0278-5846(88)90100-5","article-title":"The role of adenosine in the central actions of the benzodiazepines","volume":"12","author":"Phillis","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0245","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00449811","article-title":"Pharmacology of the benzodiazepine receptor","volume":"238","author":"Haefely","year":"1989","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0250","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0278-5846(90)90035-F","article-title":"Antidepressant\u2013anxiolytic interactions: involvement of the benzodiazepine\u2013GABA and serotonin systems","volume":"14","author":"Suranyi-Cadotte","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0255","first-page":"648","article-title":"The GABAA receptor gene family: new opportunities for drug development","volume":"6","author":"Whiting","year":"2003","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuropharm.2009.07.017","article-title":"Functional CB2 type cannabinoid receptors at CNS synapses","volume":"57","author":"Morgan","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0265","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0270","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.lfs.2006.11.009","article-title":"Quantitative structure\u2013activity relationship (QSAR) for neuroprotective activity of terpenoids","volume":"80","author":"Chang","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0275","doi-asserted-by":"crossref","first-page":"PL115","DOI":"10.1016\/S0024-3205(97)00596-1","article-title":"AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain","volume":"61","author":"Hosohata","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0280","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","article-title":"Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury","volume":"182","author":"Choi","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0285","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1021\/jf901162f","article-title":"Protective effects of the essential oil of Salvia fruticosa and its constituents on astrocytic susceptibility to hydrogen peroxide-induced cell death","volume":"57","author":"Elmann","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.physbeh.2014.06.003_bb0290","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garcia-Gutierrez","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938414003400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938414003400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:53:05Z","timestamp":1746265985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938414003400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":58,"alternative-id":["S0031938414003400"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2014.06.003","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}